Refine Results
- Applications and Industries
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
The development and manufacturing of biosimilars require comparability studies with innovator biotherapeutic products.
- Publication Part Number: 5994-1495EN
- Created: 15 Oct 2024
- 2 MB
A Comparative Study of the Intact Mass, Subunit Mass, and Released Glycans of Two Rituximab Biosimilars Using High-Resolution LC/MS
- Publication Part Number: 5994-1653EN
- Created: 15 Oct 2024
- 1 MB
LC/MS based characterization workflow of the GLP-1 therapeutic peptide liraglutide and its impurities using the 1290 Infinity II LC and 6545XT AdvanceBio LC/Q-TOF.
- Publication Part Number: 5994-7727EN
- Created: 25 Sep 2024
- 3 MB
Ultimate flexibility for more informed decisions. One instrument and multiple workflows for biopharma.
- Publication Part Number: 5991-7915EN
- Created: 28 June 2024
- 26 MB
This application note utilizes the 1260 Infinity II Bio Prime LC and InfinityLab LC/MSD iQ for the confirmation of GLP-1 (Liraglutide) sample.
- Publication Part Number: 5994-7415EN
- Created: 01 May 2024
- 1 MB
Here we introduce the ability to?confirm?multiple?sequence?hypotheses?inside ExDViewer against a single TD mixture spectrum.
- Publication Part Number: ASMS 2024 ThP025
- Created: 31 May 2024
- 962 KB
In the current study, We present a solid method for peptide quantification using capillary LC-MS/MS, emphasizing three key analytical parameters: (1) limit of detection (LOD) and limit of quantification (LOQ), (2) linear range for multiple peptides,...
- Publication Part Number: ASMS 2024 WP587
- Created: 31 May 2024
- 263 KB